Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer’s disease
- 31 August 2002
- journal article
- research article
- Published by Elsevier
- Vol. 29 (6) , 633-642
- https://doi.org/10.1016/s0969-8051(02)00326-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ ImmunizationJournal of Molecular Neuroscience, 2001
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001
- A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-Toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuranTetrahedron Letters, 1999
- Synthesis and Amyloid Binding Properties of Rhenium Complexes: Preliminary Progress Toward a Reagent for SPECT Imaging of Alzheimer's Disease BrainJournal of Medicinal Chemistry, 1999
- Images in neuroscience. Alzheimer's disease: from genes to pathogenesisAmerican Journal of Psychiatry, 1997
- Technetium Complexes for the Quantitation of Brain AmyloidJournal of the American Chemical Society, 1996
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995
- Amyloid β Protein (Aβ) in Alzheimeri's Disease BrainJournal of Biological Chemistry, 1995
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- A new and specific method for the monomethylation of primary aminesJournal of the Chemical Society, Chemical Communications, 1984